| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $28K | -24.3% | -6.7% |
| Cost of Revenue | $0 | — | -100.0% |
| R&D Expense | $923K | -7.8% | -6.2% |
| SG&A Expense | $1.7M | -10.8% | +5.3% |
| Operating Income | -$2.6M | +9.6% | -1.0% |
| Income Tax | $2K | — | — |
| Net Income | -$2.5M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $6.7M | -26.3% | +110.4% |
| Accounts Receivable | $32K | +0.0% | +10.3% |
| Current Assets | $7.6M | -21.6% | +58.7% |
| Total Assets | $9.7M | -19.1% | +43.4% |
| Current Liabilities | $2.4M | +14.3% | +1.4% |
| Total Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$6.3M | -60.4% | — |
| Capital Expenditures | $0 | — | — |
| Investing Cash Flow | $0 | — | — |
| Financing Cash Flow | $1.7M | +0.0% | — |
| Free Cash Flow | -$6.3M | -60.4% | — |
| +0.2% |
| EPS (Basic) | -$0.98 | +14.0% | -600.0% |
| EPS (Diluted) | -$0.98 | +14.0% | -600.0% |
| $2.6M |
| +7.4% |
| -14.7% |
| Stockholders' Equity | $7.1M | -25.9% | +92.0% |